Michaela McGree
University of Rochester
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michaela McGree.
Gynecologic Oncology | 2018
Ismail Mert; Amanika Kumar; Shannon P. Sheedy; Amy L. Weaver; Michaela McGree; Bohyun Kim; William A. Cliby
OBJECTIVEnAdvanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions.nnnMETHODSnPatients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤1.0cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes >7mm on the short axis; or, iii) nodes ≥10mm on the short axis. We compared overall survival (OS) using the log-rank test.nnnRESULTSnOf the 253 patients (mean age 64.0years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1%) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6months, p=0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5months, p=0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5months, p<0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5months, p=0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested.nnnCONCLUSIONnAbnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.
Annals of Epidemiology | 2008
Naomi M. Gades; Debra J. Jacobson; Michaela McGree; J.L. St. Sauver; Ajay Nehra; Michael Lieber; George G. Klee; Steven J. Jacobsen
Obstetrics & Gynecology | 2010
Sherif A. El-Nashar; M.R. Hopkins; Douglas J. Creedon; J. L. St. Sauver; Amy L. Weaver; Michaela McGree; William A. Cliby; Abimbola O. Famuyide
European Urology Supplements | 2008
Michael R. Lieber; Thomas Rhodes; Debra J. Jacobson; Michaela McGree; Cynthia J. Girman; Steven J. Jacobsen; J.L. St. Sauver
Gynecologic Oncology | 2017
Ismail Mert; Amanika Kumar; Shannon P. Sheedy; Amy L. Weaver; Michaela McGree; Bohyun Kim; B.A. Cliby
The Journal of Urology | 2011
Farzan Fatemi; Simon Kim; Debra J. Jacobson; Michaela McGree; Steven J. Jacobsen; Michael Lieber; Jennifer L. St. Sauver
/data/revues/00904295/v70i3sS/S009042950700996X/ | 2011
Steven J. Jacobsen; Debra J. Jacobson; J L St Sauver; Michaela McGree; Aruna V. Sarma; Cynthia J. Girman; Michael Lieber
The Journal of Urology | 2010
Rodney Breau; R. Jeffrey Karnes; Jacobson Debra; Michaela McGree; Steve Jacobsen; Ajay Nehra; Lieber Michael; Jennifer L. St. Sauver
The Journal of Urology | 2010
Jennifer L. St. Sauver; Debra J. Jacobson; Michaela McGree; Cynthia J. Girman; Michael Lieber; Ajay Nehra; Steven J. Jacobsen
The Journal of Urology | 2010
Matthew Tollefson; Debra J. Jacobson; Michaela McGree; Michael Lieber; Steven J. Jacobsen; Ajay Nehra; Jennifer L. St. Sauver